SOHO Insider 2025 Print Issue May/June
This issue features a letter from associate editor Dr. Elias Jabbour, a feature on CAR-T point-of-care manufacturing, and a report from SOHO Spain
Soho Print
Past Issues
News
Dr. Nieto discusses phase I results of AFM13 in lymphoma
Yago Nieto, MD, PhD, a professor at the University of Texas MD Anderson Cancer Center, discusses the results of AFM13 in a phase
ASCO 2025
Meetings / Conferences
Phase 3 VERIFY study shows rusfertide significantly improves PV outcomes over SOC
In patients with polycythemia vera (PV) receiving standard of care (SOC) therapy, treatment with rusfertide resulted in a statistically significant reduction in the
Myeloproliferative Neoplasms
SOHO Insider Podcast
Drs. Kuykendall and Hobbs on MPN care in 2025
Watch the podcast on YouTube. Andrew Kuykendall, MD, of Moffitt Cancer Center in Tampa, Florida, hosts a podcast on the latest news in
Aggressive B-Cell Lymphomas
Indolent B-Cell Lymphomas
News
NCCN recommends pemivibart for BCL patients at risk of severe COVID-19
Many patients with B-cell lymphomas experience reduced vaccine efficacy and may not mount an adequate immune response to vaccination, putting them at elevated
ASCO 2025
Meetings / Conferences
Early palliative care integration does not reduce MM patients’ healthcare utilization
Early integration of palliative care does not reduce the use of healthcare resources by patients with newly diagnosed multiple myeloma (MM) compared to
Multiple Myeloma
News
FDA panel votes 6-2 in favor of daratumumab for high-risk smoldering multiple myeloma
The US Food and Drug Administration (FDA)’s Oncologic Drugs Advisory Committee (ODAC) voted 6-2 that the results from the phase 3 AQUILA trial
Ambassador Program
News
Society Updates
SOHO Israel 2025 wraps up successful 2-day event with leading hematologists
The third meeting of SOHO Israel and 9th International Davidoff conference, titled State of the Art and Next Questions, was held on May
Lymphoma
News
FDA ODAC votes 8-1 glofitamab trial does not apply to US patients
A federal advisory panel voted 8-1 Tuesday that results from the global STARGLO trial, which was intended as the confirmatory trial for full
News
SOHO Insider Podcast
Gwen Nichols speaks with Saad Usmani on CAR-T therapy advances
Saad Usmani, MD, of Memorial Sloan Kettering Cancer Center in New York, and Gwen Nichols, MD, CMO of the Leukemia & Lymphoma Society